Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (2): 178-185.doi: 10.3969/j.issn.1000-6621.2021.02.014
• Review Articles • Previous Articles Next Articles
MI Jie, XUE Yong, BAI Xue-juan, WU Xue-qiong()
Received:
2020-09-15
Online:
2021-02-10
Published:
2021-02-03
Contact:
WU Xue-qiong
E-mail:xueqiongwu@139.com
MI Jie, XUE Yong, BAI Xue-juan, WU Xue-qiong. The research progress of lymphocyte subsets detection in diagnosis and treatment of tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 178-185. doi: 10.3969/j.issn.1000-6621.2021.02.014
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.02.014
[1] | Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol, 2001,19:93-129. doi: 10.1146/annurev.immunol.19.1.93. |
[2] | Behar SM, Martin CJ, Booty MG, et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol, 2011,4(3):279-287. doi: 10.1038/mi.2011.3. |
[3] | Kaufmann SH, Cole ST, Mizrahi V, et al. Mycobacterium tuberculosis and the host response. J Exp Med, 2005,201(11):1693-1697. doi: 10.1084/jem.20050842. |
[4] | Leveton C, Barnass S, Champion B, et al. T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun, 1989,57(2):390-395. doi: 10.1128/IAI.57.2.390-395.1989. |
[5] | Walzl G, Ronacher K, Hanekom W, et al. Immunological biomarkers of tuberculosis. Nat Rev Immunol, 2011,11(5):343-354. doi: 10.1038/nri2960. |
[6] | Wang S, Diao N, Lu C, et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS One, 2012,7(12):e51338. doi: 10.1371/journal.pone.0051338. |
[7] | Malek TR. The biology of interleukin-2. Annu Rev Immunol, 2008,26:453-479. doi: 10.1146/annurev.immunol.26.021607.090357. |
[8] | 刘士甫, 赵磊, 康书慧, 等. 菌阳肺结核患者外周血T细胞亚群的变化及意义. 现代中西医结合杂志, 2015,24(21):2360-2362. doi: 10.3969/j.issn.1008-8849.2015.21. |
[9] | Wu YE, Zhang SW, Peng WG, et al. Changes in lymphocyte subsets in the peripheral blood of patients with active pulmonary tuberculosis. J Int Med Res, 2009,37(6):1742-1749. doi: 10.1177/147323000903700610. |
[10] | 陆恩词, 朱颖蔚. 肺结核合并糖尿病患者T淋巴细胞亚群及红细胞免疫功能的变化及意义. 中国老年学杂志, 2017,37(3):648-649. doi: 10.3969/j.issn.1005-9202.2017.03.055. |
[11] | 张莉. 分析T淋巴细胞亚群在结核性胸膜炎患者外周血及胸水中的变化情况. 延安: 延安大学, 2015. |
[12] | 乔宁宁, 唐毓金, 陈文成, 等. 桂西地区骨关节结核患者T细胞亚群及红细胞表面免疫分子表达的研究. 重庆医学, 2016,45(2):196-198, 201. |
[13] | 罗武. 初治脊柱结核患者外周血T淋巴细胞亚群的变化和作用. 昆明: 昆明医科大学, 2013. |
[14] | 钟国庆, 杨庆平. T淋巴细胞亚群联合Th1/Th2细胞因子诊断肺结核患的应用价值分析. 中国实验诊断学, 2018,22(5):830-831. doi: 10.3969/j.issn.1007-4287.2018.05.020. |
[15] | 王庆枫, 韩喜琴, 陈玉玲, 等. 肺结核患者T淋巴细胞亚群的检测及临床意义. 北京医学, 2013,35(12):993-995. |
[16] | 董秋兰, 郭红革, 魏长春, 等. 耐多药肺结核患者T淋巴细胞亚群测定的临床研究. 现代预防医学, 2004,31(3):363-364. doi: 10.3969/j.issn.1003-8507.2004.03.021. |
[17] | 沈洁, 吴妹英, 李苏梅. 初治和复治肺结核患者外周血淋巴细胞亚群的变化及其临床意义. 临床肺科杂志, 2019,24(2):208-212. doi: 10.3969/j.issn.1009-6663.2019.02.004. |
[18] | 孔祥瑞, 肖漓, 石炳毅, 等. 肺结核和肺外结核患者外周血淋巴细胞亚群的表达及临床意义. 临床误诊误治, 2013,26(1):79-81. doi: 10.3969/j.issn.1002-3429.2013.01.028. |
[19] | 杨妍, 唐神结, 张青, 等. 耐多药和广泛耐药肺结核患者外周血中免疫细胞的表达及其意义. 中华结核和呼吸杂志, 2011,34(2):109-113. doi: 10.3760/cma.j.issn.1001-0939.2011.02.010. |
[20] | 蒋凛. 莫西沙星联合纤维支气管镜药物灌注治疗耐多药肺结核53例. 长江大学学报(自然科学版), 2019,16(3):97-101. doi: 10.3969/j.issn.1673-1409.2019.03.017. |
[21] | 李秀杰. 利奈唑胺治疗复治涂阳结核病的疗效及对患者T细胞亚群水平的影响. 医学理论与实践, 2019,32(13):2028-2030. doi: 10.19381/j.issn.1001-7585.2019.13.028. |
[22] | 邓国华, 姚丹, 徐改凤, 等. 金刚藤配伍抗痨药物对女性生殖器结核的治疗作用. 实用医学杂志, 2013,29(15):2547-2549. doi: 10.3969/j.issn.1006-5725.2013.15.049. |
[23] | 蒋龄周. 贞芪扶正颗粒联合抗结核药治疗肺结核临床疗效及对T淋巴细胞亚群的影响. 中医药信息, 2017,34(5):104-107. doi: 10.3969/j.issn.1002-2406.2017.05.030. |
[24] | 阳曼丽, 周桂智. 生脉饮联合黄芪注射液辅助治疗耐药肺结核的疗效评价. 陕西中医, 2016,37(11):1472-1474. doi: 10.3969/j.issn.1000-7369.2016.11.015. |
[25] | 苏宏伟, 王鹏, 齐海亮, 等. CD3、CD4、CD8T细胞亚群的表达对治疗结核性胸膜炎的疗效观察. 河北医科大学学报, 2014,35(8):930-932. doi: 10.3969/j.issn.1007-3205.2014.08.022. |
[26] | 梁艳辉, 赵磊. 胸腺五肽辅助治疗颈部淋巴结核对T淋巴细胞亚群及INF-γ和IL-10水平的影响. 现代中西医结合杂志, 2016,25(12):1336-1338. doi: 10.3969/j.issn.1008-8849.2016.12.030. |
[27] | 张洁云, 张影, 杨倩婷, 等. 结核患者治疗过程中外周血T细胞和B细胞亚群的动态变化. 中国热带医学, 2019,19(7):678-682. doi: 10.13604/j.cnki.46-1064/r.2019.07.19. |
[28] | 谢青, 李艳静. 康复新辅助治疗肺结核合并糖尿病的疗效及糖化血红蛋白与T淋巴细胞亚群相关性的研究. 临床合理用药杂志, 2014,7(2):71-72. |
[29] | 高敏. 健脾活血中药联合抗结核化疗方案治疗肠结核疗效及对T淋巴细胞亚群、肠黏膜屏障功能的影响. 现代中西医结合杂志, 2018,27(3):308-311. doi: 10.3969/j.issn.1008-8849.2018.03.024. |
[30] | 陶成武. 基于多色流式细胞术的结核病患者T细胞亚群研究. 扬州: 扬州大学, 2017. |
[31] | Li K, Ran R, Jiang Z, et al. Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis. Infection, 2020,48(4):585-595. doi: 10.1007/s15010-020-01451-2. |
[32] | 戴建义, 苏菲菲, 杨守峰, 等. 复治结核病患者外周血中淋巴细胞亚群变化及其临床意义. 中国医师杂志, 2012,2增刊(下册):76-77. |
[33] | 陆明娇. 外周血T淋巴细胞亚群在结核、糖尿病、肺炎患者中的变化情况及意义探讨. 南充: 川北医学院, 2018. doi: CNKI:CDMD:2.1018.092366. |
[34] | 高变. 肺结核患者外周血腺苷脱氨酶活性与T淋巴细胞亚群定量检测的相关性及临床意义研究. 苏州: 苏州大学, 2012. doi: 10.7666/d.D290557. |
[35] | 何畏, 陈晴, 黄涛, 等. 肺结核及肺外结核患者外周血T淋巴细胞亚群的变化及其临床意义. 中国防痨杂志, 2019,41(10):1090-1095. doi: 10.3969/j.issn.1000-6621.2019.10.005. |
[36] | 何纲, 丁佩佩, 甄沛林, 等. 非耐药与耐多药肺结核患者外周血T淋巴细胞亚群及细胞因子的变化. 中国感染控制杂志, 2013,12(5):326-329. doi: 10.3969/j.issn.1671-9638.2013.05.002. |
[37] | Baluku JB, Musaazi J, Mulwana R, et al. Prevalence and Predictors of CD4+ T-Lymphocytopenia Among HIV-Negative Tuberculosis Patients in Uganda. Res Rep Trop Med, 2020,11:45-51. doi: 10.2147/RRTM.S252550. |
[38] | 张国栋. 初治涂阳肺结核患者经强化期治疗后T细胞亚群的变化. 临床肺科杂志, 2017,22(5):795-797. doi: 10.3969/j.issn.1009-6663.2017.05.006. |
[39] | 韩莉. 莫西沙星联合环丝氨酸治疗耐多药肺结核的临床疗效. 实用心脑肺血管病杂志, 2018,26(4):136-138. doi: 10.3969/j.issn.1008-5971.2018.04.036. |
[40] | 李媛媛, 苏东栋, 哈米提·努力克. 两种非吡嗪酰胺化疗方案治疗肺结核合并糖尿病高尿酸血症的临床研究. 中国处方药, 2017,15(8):84-85. doi: 10.3969/j.issn.1671-945X.2017.08.059. |
[41] | Lewinsohn DA, Heinzel AS, Gardner JM, et al. Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med, 2003,168(11):1346-1352. doi: 10.1164/rccm.200306-837OC. |
[42] | 宋华峰, 袁丹丹, 陈慧, 等. 耐多药肺结核患者外周血中淋巴细胞比例变化分析. 临床肺科杂志, 2018,23(3):391-395. doi: 10.3969/j.issn.1009-6663.2018.03.002. |
[43] | 罗丹, 潘建华. T淋巴亚群及T-SPOT.TB检测对活动性结核病的鉴别诊断. 中国热带医学, 2015,15(4):393-396. |
[44] | 许建民. 初治肺结核患者T淋巴细胞亚群和Th细胞的变化及与预后的关系. 中国当代医药, 2014,21(28):40-42, 45. |
[45] | 傅京力. T细胞和相关细胞因子在肺结核患者中的动态变化及临床意义. 长沙: 中南大学, 2014. |
[46] | 李敏. 青蒿鳖甲汤加减对结核性肛瘘创面愈合及T淋巴细胞亚群的影响研究. 贵阳: 贵阳中医学院, 2017. doi: CNKI:CDMD:2.1019.014533. |
[47] | 张砚, 朱凌云, 左维泽, 等. 2型糖尿病患者结核分枝杆菌感染糖化血红蛋白与T 淋巴细胞亚群的水平变化相关性研究. 中华医院感染学杂志, 2015,25(18):4119-4121. doi: 10.11816/cn.ni.2015-150485. |
[48] | 唐佩军. 基于肺结核患者T细胞免疫特征分析的细胞免疫治疗疗效的初步研究. 苏州: 苏州大学, 2017. doi: CNKI:CDMD:1.1018.022643. |
[49] | 王建华, 尉理梁, 张秀军, 等. 57例矽肺结核患者外周血T淋巴细胞亚群的检测及分析. 中华危重症医学杂志(电子版), 2014,7(6):48-49. doi: 10.3877/cma.j.issn.1674-6880.2014.06.012. |
[50] | 唐神结. 慢性阻塞性肺疾病合并肺结核患者体液和细胞免疫功能的研究. 苏州: 苏州大学, 2014. |
[51] | 宫玉杰, 熊延青. 结核方联合胸腺肽对难治性肺结核的疗效及外周血T淋巴细胞亚群的影响. 中医药导报, 2016,22(11):70-72. |
[52] | 胡家美, 乐敏莉, 向方华, 等. 复方竹节参联合抗结核药治疗骨结核的临床效果及对T淋巴细胞亚群的影响研究. 重庆医学, 2017,46(33):4727-4729. doi: 10.3969/j.issn.1671-8348.2017.33.040. |
[53] | 谢青, 张亚楠, 李艳静, 等. 抗结核药物联合胸腺五肽对结核性脑膜炎患者外周血中T淋巴细胞亚群的影响. 中国实用神经疾病杂志, 2014,17(12):61-62. |
[54] | 吴成周, 吴砚樵. 肺结核患者 T 细胞亚群及炎性因子水平对患者预后的影响. 海南医学院学报, 2016,22(15):1660-1662. doi: 10.13210/j.cnki.jhmu.20160422.001. |
[55] | 戴建义, 苏菲菲, 杨守峰, 等. 复治肺结核病患者外周血淋巴细胞亚群变化及临床意义. 上海预防医学, 2014,26(4):180-181. |
[56] | 高琼瑶. 肺结核患者T细胞亚群检测的临床意义. 延安: 延安大学, 2015. |
[57] | 陈雪芳, 许文芳. 活动期肺结核患者外周血miR-29a的表达及其临床意义. 中国微生态学杂志, 2017,29(12):1416-1419,1423. doi: 10.13381/j.cnki.cjm.201712012. |
[58] | Chen YC, Chang HC, Chen CJ, et al. Blood absolute T cell counts may predict 2-month treatment response in patients with pulmonary tuberculosis. Dis Markers, 2010,28(6):343-352. doi: 10.3233/DMA-2010-0714. |
[59] | 丁爱华, 王尚武. 淋巴结核患者外周血中T淋巴细胞亚群的检测及其意义. 国际检验医学杂志, 2012,33(20):2547-2549. doi: 10.3969/j.issn.1673-4130.2012.20.051. |
[60] | 熊先明, 梁亚君, 柯静, 等. 两种氟喹诺酮类抗生素辅助利福布汀治疗MDR-TB临床对比研究. 河北医药, 2017,39(6):883-885. doi: 10.3969/j.issn.1002-7386.2017.06.023. |
[61] | 赵磊, 狄岩, 王瑜玲, 等. 常规抗结核药物联合经支气管镜冷冻治疗支气管结核的临床疗效及其对免疫功能的影响研究. 中国全科医学, 2016,19(29):3554-3557. doi: 10.3969/j.issn.1007-9572.2016.29.009. |
[62] | 张亚平. 胸腺肽α1联合抗结核方案治疗肺结核合并糖尿病临床效果及对外周血T淋巴细胞亚群的影响. 中国医学工程, 2019,27(10):99-101. doi: 10.19338/j.issn.1672-2019.2019.10.030. |
[63] | 王和林. 芪甲利肺胶囊辅助治疗复治肺结核合并2型糖尿病的临床意义. 新乡: 新乡医学院, 2016. doi: CNKI:CDMD:2.1016.185855. |
[64] | 廖春信, 方毅敏, 詹晓霞, 等. 肺结核患者外周血 CD4+CD8+T 细胞的检测及临床意义. 中华微生物学和免疫学杂志, 2014,34(10):781-786. doi: 10.3760/cma.j.issn.0254-5101.2014.10.011. |
[65] | 诸雪萍, 孙小军, 许文芳. 外周血DPT细胞对肺结核患者预后的评估价值. 中国现代医学杂志, 2015,25(22):50-54. |
[66] | 陈向红, 白敏, 张造章, 等. 淋巴细胞功能测定对常见肺部疾病的临床意义. 实用医学杂志, 2019,35(20):3204-3207. doi: 10.3969/j.issn.1006-5725.2019.20.018. |
[67] | 栗群英, 吴丽娟, 陈莉, 等. 结核病患者T细胞亚群检测临床意义分析. 国际检验医学杂志, 2012,33(19):2346-2347. doi: 10.3969/j.issn.1673-4130.2012.19.021. |
[68] | 邓威. 结核病患者外周血T细胞亚群检测的临床价值研究. 中国卫生检验杂志, 2017,27(18):2677-2678, 2685. |
[69] | 张平骥, 戴丽, 李天水, 等. DNT细胞在胸腔积液鉴别诊断中的意义. 中国医刊, 2018,53(9):972-974. doi: 10.3969/j.issn.1008-1070.2018.09.006. |
[70] | Cerundolo V, Kronenberg M. The role of invariant NKT cells at the interface of innate and adaptive immunity. Semin Immunol, 2010,22(2):59-60. doi: 10.1016/j.smim.2010.01.002. |
[71] | 张青, 肖和平. T细胞、NKT和NK细胞在结核病诊断中的意义探讨. 中国防痨杂志, 2010,32(5):267-271. |
[72] | 张青, 肖和平, 王颖, 等. 肺结核合并糖尿病患者自然杀伤T细胞的变化特点. 中华结核和呼吸杂志, 2011,34(2):114-116. |
[73] | Morais-Papini TF, Coelho-Dos-Reis JGA, Wendling APB, et al. Systemic Immunological changes in patients with distinct clinical outcomes during Mycobacterium tuberculosis infection. Immunobiology, 2017,222(11):1014-1024. doi: 10.1016/j.imbio.2017.05.016. |
[74] | 张红, 谢跃文. 肺结核患者血浆Ficolin-2的表达及T细胞亚群的变化. 临床血液学杂志, 2019,32(2):127-129. doi: 10.13201/j.issn.1004-2806-b.2019.02.013. |
[75] | 唐佩军, 吴妹英, 王霞芳, 等. T淋巴细胞亚群活化和可溶性白细胞介素2受体在结核性胸膜炎中的作用. 结核病与肺部健康杂志, 2017,6(2):122-124. doi: 10.3969/j.issn.2095-3755.2017.02.009. |
[76] | 张占军. 慢性阻塞性肺疾病合并肺结核患者T淋巴细胞亚群及相关细胞因子的变化和意义. 苏州: 苏州大学, 2014. |
[77] | 刘宁, 苏明霞, 李雯, 等. 肺结核患者肺泡灌洗液及外周血淋巴细胞亚群检测分析. 中国临床医生杂志, 2016,44(4):49-51. doi: 10.3969/j.issn.2095-8552.2016.04.015. |
[78] | 胡爱明, 童轶, 何卫. 香菇多糖对糖尿病合并肺结核化学治疗疗效的影响. 临床肺科杂志, 2013,18(8):1526-1527. doi: 10.3969/j.issn.1009-6663.2013.08.090. |
[79] | 陶叶海. 抗结核急性药物性肝损伤患者外周血T细胞亚群和NK细胞水平研究. 中国卫生检验杂志, 2013,23(18):3549-3551. |
[80] | Kulpraneet M, Sukwit S, Sumransurp K, et al. Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients. Southeast Asian J Trop Med Public Health, 2007,38(2):370-375. |
[81] | 邱晓静, 王兆华, 王健, 等. 肺结核患者外周血NK细胞数量和胞内杀伤分子的变化. 蚌埠医学院学报, 2012,37(10):1141-1144. doi: 10.3969/j.issn.1000-2200.2012.10.001. |
[82] | Rao M, Valentini D, Poiret T, et al. B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis. Clin Infect Dis, 2015,61Suppl 3:S225-234. doi: 10.1093/cid/civ614. |
[83] | Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev, 2015,264(1):167-181. doi: 10.1111/imr.12276. |
[84] | Maglione PJ, Xu J, Chan J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Immunol, 2007,178(11):7222-7234. doi: 10.4049/jimmunol.178.11.7222. |
[85] | 杜光明. 肺结核和肺外结核患者外周血淋巴细胞亚群的检测意义探讨. 临床肺科杂志, 2014,19(4):693-695. doi: 10.3969/j.issn.1009-6663.2014.04.038. |
[86] | 郑乐朋, 刘春艳, 刘文渊. 结核感染T细胞检测阳性患儿T淋巴细胞亚群的变化. 中国卫生检验杂志, 2015,25(21):3669-3670. |
[87] | Hernandez J, Velazquez C, Valenzuela O, et al. Low number of peripheral blood B lymphocytes in patients with pulmonary tuberculosis. Immunol Invest, 2010,39(3):197-205. doi: 10.3109/08820130903586346. |
[88] | Guglielmetti L, Cazzadori A, Conti M, et al. Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay. Int J Tuberc Lung Dis, 2013,17(6):825-828. doi: 10.5588/ijtld.12.0361. |
[1] | WANG Qian, LI Tao, DU Xin, NI Ni, ZHAO Yan-lin, ZHANG Hui. The analysis of national tuberculosis reported incidence and mortality, 2015—2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 107-112. |
[2] | KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong. Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118. |
[3] | ZHANG Guang-chuan, LAI Keng, DU Yu-hua, WU Gui-feng, LEI Yu, SHEN Hong-cheng, YANG Jie-ying, LIN Ying, ZHONG Min-er, ZHONG Zhi-qing, LIU Li, LI Tie-gang. Analysis of epidemiological characteristics of smear-positive tuberculosis patients in Guangzhou from 2014 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 119-125. |
[4] | YE Jin-xin, XU Lin, CHEN Jin-ou, QIU Yu-bing, LYU Tong. Analysis of influencing factors of death in TB patients complicated with AIDS during anti-tuberculosis treatment in Yunnan, 2011-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 126-131. |
[5] | WANG Pei, ZHAO Guo-lian, LEI Qian, ZHENG Dan, CUI Xiao-li, ZHOU Jun. Comparison of the clinical application between fluorescence PCR probe melting curve and Micropore-plate method in determining the drug resistance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 132-138. |
[6] | LU Ni-hong, SUN Ya-ping, JIN Yuan, XIA Jia-wei, YANG Yong-rui. Application value of ESAT-6 combined with MMP-9 in assessing the severity of tuberculosis destroyed lung [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 139-142. |
[7] | CUI Xiao-jing, WEI Dong, WANG Chun-lei, CAO Bin. Value of molecular diagnosis and liquid culture methods in improving the pathogenic diagnosis of pulmonary tuberculosis in general hospitals [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 143-146. |
[8] | WANG Xiu-jun, LIU Qiu-yue, CHEN Xiao-feng, YU Lei, MA Yan, HAN Fen. Study on plasma proteomics of patients with secondary pulmonary tuberculosis based on label-free quantitative technology [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 159-165. |
[9] | JI Le-cai, ZHANG Le-ping, LYU Jian-wen, LI Xiao-ding, ZOU Xiao-fei, PIAO Wei. Whole-genome sequencing for drug resistance profile prediction in multidrug-resistant Mycobacterium tuberculosis in Shenzhen [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 166-170. |
[10] | FEI Jun, SHI Shi-yuan, HU Sheng-ping, HU De-xin, ZHANG Chen-wei. Biomechanical study of cortical bone trajectory screw in lumbar spine tuberculosis intervertebral fixation [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 171-177. |
[11] | GUO Qian, SHEN Chen, SHEN A-dong. Research progress of stem cells in Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 186-189. |
[12] | CAO Xin-yu, XUE Miao, WEN Yan, LIU Li. Research progress on susceptibility genes of anti-tuberculous drug-induced liver injury [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 190-193. |
[13] | LIU Wen-feng, ZHOU Lin, XU Tian-liang, YI Huai-ming, WANG Yong, WANG Qian-xin. Evaluation of the implementation effect of “mobile tuberculosis clinic” service in the prevention and control of tuberculosis in Changshan County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 100-102. |
[14] | National Clinical Research Center for Infectious Disease/, The Third People’s Hospital of Shenzhen, National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital of Central South University, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Expert consensus on treatment and management of tuberculosis-diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 12-22. |
[15] | HU Wei-hua, JIN Long, CHU Nai-hui. Analysis of drug resistance characteristics of MDR/XDR-TB patients complicated with type 2 diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 26-30. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||